IL‐1 Receptor Antagonist in Combination with Pentoxifylline and Zinc for Severe Alcoholic Hepatitis: A Multicenter Randomized Double‐Bind Placebo‐Controlled Clinical Trial | Zendy

Gyöngyi Szabó | Zendy; Mack C. Mitchell | Zendy; Craig J. McClain | Zendy; Srinivasan Dasarathy | Zendy; Arthur Mccullough | Zendy; Laura E. Nagy | Zendy; Aimee KrollDesrosiers | Zendy; Svetlana Radaeva | Zendy; Bruce Barton | Zendy; Aimee Kroll | Zendy; Masatoshi Kudo | Zendy; Ana Matilla | Zendy; Armando Santoro | Zendy; Ignacio Melero | Zendy; Antonio Cubillo Gracián | Zendy; Mirelis Rivera Acosta | Zendy; Su Pin Choo | Zendy; Anthony B. El-Khoueiry | Zendy; Ryoko Kuromatsu | Zendy; Bassel El Rayes | Zendy; Kazushi Numata | Zendy; Yoshito Itoh | Zendy; Francesco Di Costanzo | Zendy; Oxana Crysler | Zendy; María Reig | Zendy; Yun Shen | Zendy; Jaclyn Neely | Zendy; Christine Dela Cruz | Zendy; Carlos Baccan | Zendy; Bruno Sangro | Zendy; H. Gregorio Marañon | Zendy; Michael Galambos | Zendy; Aparna Goel | Zendy; Andreas E. Kremer | Zendy; Yvonne Dörffel | Zendy; Paul J. Thuluvath | Zendy; David Sheridan | Zendy; Carmen Stanca | Zendy; Christoph P. Berg | Zendy; Lynsey Corless | Zendy; Marcus-Alexander Woerns | Zendy; Norman Gitlin | Zendy; Mónika Varga | Zendy; David Jones | Zendy; Joseph A. Odin | Zendy; Charles Landis | Zendy; Hemant Shah | Zendy; Gianni Amato | Zendy; S Rosenbusch | Zendy; Rohit Loomba | Zendy; Joel Neutel | Zendy; David W. Bernard | Zendy; Randall Severance | Zendy; Rizwana Mohseni | Zendy; Michael Dao | Zendy; Satinder Saini | Zendy; Carmen Margaritescu | Zendy; Ken Homer | Zendy; Brian Tran | Zendy; Marianne Mancini | Zendy; Hiroko Masamune | Zendy; Brian W. Lian | Zendy; Rohit Loomba -Gilead | Zendy; David Bernard -Chear | Zendy

Premium

IL‐1 Receptor Antagonist in Combination with Pentoxifylline and Zinc for Severe Alcoholic Hepatitis: A Multicenter Randomized Double‐Bind Placebo‐Controlled Clinical Trial

Author(s) -

Gyöngyi Szabó,

Mack C. Mitchell,

Craig J. McClain,

Srinivasan Dasarathy,

Arthur Mccullough,

Laura E. Nagy,

Aimee KrollDesrosiers,

Svetlana Radaeva,

Bruce Barton,

Aimee Kroll,

Masatoshi Kudo,

Ana Matilla,

Armando Santoro,

Ignacio Melero,

Antonio Cubillo Gracián,

Mirelis Rivera Acosta,

Su Pin Choo,

Anthony B. El-Khoueiry,

Ryoko Kuromatsu,

Bassel El Rayes,

Kazushi Numata,

Yoshito Itoh,

Francesco Di Costanzo,

Oxana Crysler,

María Reig,

Yun Shen,

Jaclyn Neely,

Christine Dela Cruz,

Carlos Baccan,

Bruno Sangro,

H. Gregorio Marañon,

Michael Galambos,

Aparna Goel,

Andreas E. Kremer,

Yvonne Dörffel,

Paul J. Thuluvath,

David Sheridan,

Carmen Stanca,

Christoph P. Berg,

Lynsey Corless,

Marcus-Alexander Woerns,

Norman Gitlin,

Mónika Varga,

David Jones,

Joseph A. Odin,

Charles Landis,

Hemant Shah,

Gianni Amato,

S Rosenbusch,

Rohit Loomba,

Joel Neutel,

David W. Bernard,

Randall Severance,

Rizwana Mohseni,

Michael Dao,

Satinder Saini,

Carmen Margaritescu,

Ken Homer,

Brian Tran,

Marianne Mancini,

Hiroko Masamune,

Brian W. Lian,

Rohit Loomba -Gilead,

David Bernard -Chear

Publication year - 2018

Publication title -

hepatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.488

H-Index - 361

eISSN - 1527-3350

pISSN - 0270-9139

DOI - 10.1002/hep.30353

Subject(s) - pentoxifylline , medicine , placebo , antagonist , alcoholic hepatitis , multicenter trial , randomized controlled trial , gastroenterology , pharmacology , receptor antagonist , clinical trial , receptor , multicenter study , alcoholic liver disease , pathology , cirrhosis , alternative medicine

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research